Is Synopsys a Buy After Falling 35% From Its High?

Synopsys Is Recovering From a 35% Drop. Is the Worst Finally Over?

Synopsys, Inc. (SNPS) has just transitioned from a period of intense selling pressure into a recovery phase, yet it remains firmly within our highest risk category. As of April 14, 2026, the stock has spent 207 days in a drawdown, a duration that significantly exceeds its historical average of 53 days. While the price is beginning to stabilize, our data shows that the current Drawdown Severity Score™ of 6.7 keeps the stock in the "red zone," indicating that despite recent gains, the technical damage remains substantial compared to historical norms.

When we look at how other high-growth technology stocks recover from similar Drawdown Severity Score™ levels, the path is rarely a straight line. For example, NVIDIA (NVDA) and Cadence Design Systems (CDNS) have historically faced prolonged consolidation periods when their severity scores crossed the 6.0 threshold. Our data indicates that once a stock enters this "Very Strong" drawdown intensity, the market requires significant fundamental proof to shift the sentiment back toward the green zone.

Breaking Down the 207-Day Decline

The current drawdown for Synopsys (SNPS) stands at -35.3% as of April 14, 2026. This is a sharp departure from the stock's typical behavior, as its average max drawdown over 223 historical events is only -5.7%. The stock is currently trading at $417.77, which is more than $227 below its all-time high of $645.35.

This current 207-day stretch represents a significant test of investor patience. Our data shows that Synopsys (SNPS) usually resolves its pullbacks much faster. The fact that the stock remains in the red zone after nearly seven months suggests that the overhead resistance is heavy. According to Traders Union, technical indicators favor consolidation as the stock hovers near a resistance level of $425.

The Drawdown Severity Score™ of 6.7 is the primary metric we use to gauge the intensity of this sell-off. Even though the stock has seen recent upward movement, the severity score remains high because the price is still significantly distanced from its peak. We have observed that stocks in the red zone often experience "false starts" where they rally briefly before retesting local lows.

How SNPS Compares to Its Own History

To understand the magnitude of the current situation, we must look at the rarest events in the company's history. Our data shows that Synopsys (SNPS) has only dropped 40% or more 3 times in its entire history. This is a small sample size, which suggests that the current -35.3% drawdown is approaching a "worst-case" historical boundary for the company.

In those 3 instances where the stock dropped more than 40%, the average duration of the comparable drops was 1898 days. It is important to note this caveat: because these massive drawdowns are so rare for this specific ticker, the average duration is skewed by long recovery cycles from major market shifts. At 207 days, the current event is still relatively young if it follows the trajectory of those rare, deep corrections.

The current Drawdown Severity Score™ of 6.7 highlights that this is not a routine dip. Most of the 223 drawdown events we have tracked for this stock were minor fluctuations that lasted less than two months. By contrast, the current event has lasted nearly four times longer than the average.

AI Tailwinds and Institutional Activity

The fundamental backdrop for Synopsys (SNPS) provides context for why the stock is attempting to claw back from the red zone. According to Quiver Quantitative, there is significant optimism regarding AI chip design tailwinds, which could serve as a long-term catalyst for the company's software suite. Furthermore, Seeking Alpha reports that a stake from Elliott Management confirms the company's attraction and reinforces a positive outlook for some analysts.

However, institutional activity has been mixed during this 207-day drawdown. MarketBeat reports that Baillie Gifford & Co. recently sold 5,454 shares of Synopsys (SNPS). This type of institutional trimming can create headwinds for a stock trying to exit a deep drawdown. While GuruFocus suggests the stock is up 6.5% recently and remains undervalued, our Drawdown Severity Score™ reminds us that "undervalued" does not mean "low risk."

The company also recently posted its financial results for the first quarter of fiscal year 2026. While these results provide the latest fundamental data, the stock price reaction has been measured. Yahoo Finance noted that the stock has experienced drops even during days of broader market gains, which is a hallmark of a stock struggling with a high severity score.

The Road Back to the Green Zone

For Synopsys (SNPS) to exit the red zone and move toward a more stable severity score, it must bridge the gap between its current price of $417.77 and its all-time high of $645.35. That is a 35.3% climb from current levels just to break even. Our data suggests that the transition from the red zone to the yellow zone typically requires a sustained period of lower volatility and consistent price appreciation.

Investors monitoring the Drawdown Severity Score™ should watch for a reduction in the score below 6.0 as the first sign of a meaningful shift in momentum. Until that happens, the stock remains in a high-risk technical state. The history of Synopsys (SNPS) shows a stock that usually recovers quickly, but the current 207-day event is proving to be an outlier.

We will continue to track whether the AI design tailwinds are enough to overcome the technical damage sustained over the last seven months. The proprietary data shows a stock at a crossroads: it is either finding a floor near the -35% mark or it is entering a prolonged period of underperformance similar to the 3 other major drops in its history.